Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Editorial

Contemporary Management of Risk Factors in Coronary Artery Disease (Part 2)

Author(s): Dimitris Tousoulis and Panagiotis Theofilis

Volume 29, Issue 35, 2023

Published on: 07 December, 2023

Page: [2763 - 2763] Pages: 1

DOI: 10.2174/138161282935231207112504

Price: $65

Next »
[1]
Siasos G, Tsigkou V, Bletsa E, et al. Antithrombotic treatment in coronary artery disease. Curr Pharm Des 2023; 29(35): 2764-79.
[2]
Tsioufis PA, Theofilis P, Vlachakis PK, et al. Novel invasive methods as the third pillar for the treatment of essential uncontrolled hypertension. Curr Pharm Des 2023; 29(35): 2780-6.
[3]
Sagris M, Theofilis P, Papanikolaou A, et al. Direct oral anticoagulants use in patients with stable coronary artery disease, acute coronary syndrome or undergoing percutaneous coronary intervention. Curr Pharm Des 2023; 29(35): 2787-94.
[4]
Papastamos C, Antonopoulos AS, Simantiris S, et al. Stem cell-based therapies in cardiovascular diseases: From pathophysiology to clinical outcomes. Curr Pharm Des 2023; 29(35): 2795-801.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy